Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Torp-Pedersen

Showing results (21-30 of 1,324) with videos related to

Pageof 133
Sort By:
Journal of the American College of Cardiology|October 20, 2018
Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?Christina Ji-Young Lee, Christian Torp-Pedersen
American Heart Journal|June 17, 2004
Atrial fibrillation and atrial cardiomyopathy--two sides of the same coin?Ole Dyg Pedersen, Lars Køber, Christian Torp-Pedersen
Clinical Interventions in Aging|April 17, 2010
Impact of dronedarone in atrial fibrillation and flutter on stroke reductionChristine Benn Christiansen, Christian Torp-Pedersen, Lars Køber
Journal of the American College of Cardiology|April 10, 2010
Antiarrhythmic drugs safety firstChristian Torp-Pedersen, Ole Dyg Pedersen, Lars Køber
Cardiac Electrophysiology Review|May 2, 2002
Arrhythmic and sudden death in chronic ischemic heart disease--a review of epidemiological dataSteen Z Abildstrom, Christian Torp-Pedersen, Lars Køber
Expert Opinion on Drug Safety|December 17, 2009
Efficacy and safety of dronedarone: a review of randomized trialsChristine Benn Christiansen, Christian Torp-Pedersen, Lars Køber
European Heart Journal|August 4, 2022
Primary lifestyle intervention: the challenge of making a differenceChristian Torp-Pedersen, Kathrine Kold Sørensen, Charlotte Andersson
Scandinavian Journal of Public Health|July 22, 2011
Register-based studies of cardiovascular diseaseSteen Z Abildstrøm, Christian Torp-Pedersen, Mette Madsen
European Heart Journal|January 19, 2008
Heart failure with preserved ejection fraction: dangerous, elusive, and difficultOlav W Nielsen, Lars Køber, Christian Torp-Pedersen
European Heart Journal|March 11, 2026
Risk Scores for Heart Failure: Powerful for Populations, Problematic for the individual PatientChristian Torp-Pedersen, Kristian Hay Kragholm, Lars Køber
Pageof 133

Showing results (21-30 of 1,324) with videos related to

Sort By:
Pageof 133
Journal of the American College of Cardiology|October 20, 2018
Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?Christina Ji-Young Lee, Christian Torp-Pedersen
American Heart Journal|June 17, 2004
Atrial fibrillation and atrial cardiomyopathy--two sides of the same coin?Ole Dyg Pedersen, Lars Køber, Christian Torp-Pedersen
Clinical Interventions in Aging|April 17, 2010
Impact of dronedarone in atrial fibrillation and flutter on stroke reductionChristine Benn Christiansen, Christian Torp-Pedersen, Lars Køber
Journal of the American College of Cardiology|April 10, 2010
Antiarrhythmic drugs safety firstChristian Torp-Pedersen, Ole Dyg Pedersen, Lars Køber
Cardiac Electrophysiology Review|May 2, 2002
Arrhythmic and sudden death in chronic ischemic heart disease--a review of epidemiological dataSteen Z Abildstrom, Christian Torp-Pedersen, Lars Køber
Expert Opinion on Drug Safety|December 17, 2009
Efficacy and safety of dronedarone: a review of randomized trialsChristine Benn Christiansen, Christian Torp-Pedersen, Lars Køber
European Heart Journal|August 4, 2022
Primary lifestyle intervention: the challenge of making a differenceChristian Torp-Pedersen, Kathrine Kold Sørensen, Charlotte Andersson
Scandinavian Journal of Public Health|July 22, 2011
Register-based studies of cardiovascular diseaseSteen Z Abildstrøm, Christian Torp-Pedersen, Mette Madsen
European Heart Journal|January 19, 2008
Heart failure with preserved ejection fraction: dangerous, elusive, and difficultOlav W Nielsen, Lars Køber, Christian Torp-Pedersen
European Heart Journal|March 11, 2026
Risk Scores for Heart Failure: Powerful for Populations, Problematic for the individual PatientChristian Torp-Pedersen, Kristian Hay Kragholm, Lars Køber
Pageof 133